Breaking News Instant updates and real-time market news.

PEI

Pennsylvania REIT

$1.25 /

+0.2 (+19.05%)

17:09
08/10/20
08/10
17:09
08/10/20
17:09

Pennsylvania REIT reports Q2 adjusted FFO (6c), consensus 8c

Reports Q2 revenue $56.77M, consensus $75.45M. "We continue to be appreciative of our PREIT associates for executing on all aspects of our plan to get through this challenging period. Our resolve in creating the best overall consumer experience remains," said CEO Joseph Coradino. "Long before this pandemic hit, we were responding to changes in consumer behavior. Our properties have superior market positioning as dominant retail hubs and we believe they will continue to gain market share as we strengthen them into commerce districts that include apartments, hotels, storage and last-mile fulfillment, medical and other uses. Our go-forward capital allocation priorities are to ensure that only the best opportunities to bolster our underlying earnings stream are pursued."

  • 11

    Aug

PEI Pennsylvania REIT
$1.25 /

+0.2 (+19.05%)

03/26/20 RBC Capital
Cheesecake, AMC news highlight tenants financial stress, says RBC Capital
01/16/20 Truist
Pennsylvania REIT downgraded to Sell from Hold at SunTrust
01/15/20 Truist
Pennsylvania REIT downgraded to Sell from Hold at SunTrust
09/23/19 Citi
Pennsylvania REIT downgraded to Sell from Neutral at Citi

TODAY'S FREE FLY STORIES

Upgrade
WPX Energy upgraded to Buy from Hold at Truist » 07:29
09/22/20
09/22
07:29
09/22/20
07:29
WPX

WPX Energy

$4.51 /

-0.27 (-5.65%)

Truist analyst Neal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WPX WPX Energy
$4.51 /

-0.27 (-5.65%)

WPX WPX Energy
$4.51 /

-0.27 (-5.65%)

05:18 Today Truist
WPX Energy upgraded to Buy from Hold at Truist
09/14/20 Northland
WPX Energy downgraded to Market Perform from Outperform at Northland
07/27/20 Seaport Global
WPX Energy initiated with a Neutral at Seaport Global
07/20/20 Northland
WPX Energy price target raised to $7.50 from $7 at Northland
WPX WPX Energy
$4.51 /

-0.27 (-5.65%)

WPX WPX Energy
$4.51 /

-0.27 (-5.65%)

WPX WPX Energy
$4.51 /

-0.27 (-5.65%)

Recommendations
Semi cap pullback an attractive entry point in Applied Materials, says Stifel » 07:28
09/22/20
09/22
07:28
09/22/20
07:28
AMAT

Applied Materials

$57.33 /

+1.17 (+2.08%)

Stifel analyst Patrick Ho…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMAT Applied Materials
$57.33 /

+1.17 (+2.08%)

AMAT Applied Materials
$57.33 /

+1.17 (+2.08%)

08/17/20 Citi
Applied Materials price target raised to $75 from $62 at Citi
08/14/20 DA Davidson
Applied Materials price target raised to $70 from $55 at DA Davidson
08/14/20 B. Riley FBR
Applied Materials price target raised to $82 from $72 at B. Riley FBR
08/14/20 Craig-Hallum
Applied Materials price target raised to $83 from $79 at Craig-Hallum
AMAT Applied Materials
$57.33 /

+1.17 (+2.08%)

AMAT Applied Materials
$57.33 /

+1.17 (+2.08%)

AMAT Applied Materials
$57.33 /

+1.17 (+2.08%)

AMAT Applied Materials
$57.33 /

+1.17 (+2.08%)

Recommendations
Rocket Pharmaceuticals price target lowered to $33 from $43 at Oppenheimer » 07:27
09/22/20
09/22
07:27
09/22/20
07:27
RCKT

Rocket Pharmaceuticals

$23.82 /

-2.1 (-8.10%)

Oppenheimer analyst Kevin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RCKT Rocket Pharmaceuticals
$23.82 /

-2.1 (-8.10%)

RCKT Rocket Pharmaceuticals
$23.82 /

-2.1 (-8.10%)

09/10/20 SMBC Nikko
Rocket Pharmaceuticals initiated with an Outperform at SMBC Nikko
08/05/20 Piper Sandler
Rocket readouts should create 'substantial value,' says Piper Sandler
07/21/20 Piper Sandler
Rocket shares should be owned through year-end, says Piper Sandler
07/02/20 JPMorgan
Rocket Pharmaceuticals initiated with an Overweight at JPMorgan
RCKT Rocket Pharmaceuticals
$23.82 /

-2.1 (-8.10%)

  • 11
    Dec
Upgrade
Matador upgraded to Buy from Hold at Truist » 07:25
09/22/20
09/22
07:25
09/22/20
07:25
MTDR

Matador

$8.55 /

-0.3 (-3.39%)

Truist analyst Neal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MTDR Matador
$8.55 /

-0.3 (-3.39%)

MTDR Matador
$8.55 /

-0.3 (-3.39%)

05:11 Today Truist
Matador upgraded to Buy from Hold at Truist
09/14/20 Wells Fargo
Matador upgraded to Overweight from Equal Weight at Wells Fargo
07/29/20 Northland
Matador guidance seems conservative after 'big beat' in Q2, says Northland
07/23/20
Fly Intel: Top five analyst downgrades
MTDR Matador
$8.55 /

-0.3 (-3.39%)

MTDR Matador
$8.55 /

-0.3 (-3.39%)

MTDR Matador
$8.55 /

-0.3 (-3.39%)

Conference/Events
Blucora participates in a conference call with Benchmark » 07:25
09/22/20
09/22
07:25
09/22/20
07:25
BCOR

Blucora

$9.04 /

+0.06 (+0.67%)

Services Analyst Kurnos…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BCOR Blucora
$9.04 /

+0.06 (+0.67%)

BCOR Blucora
$9.04 /

+0.06 (+0.67%)

08/05/20 Barrington
Blucora price target lowered to $15 from $18 at Barrington
02/19/20 William Blair
Blucora shares will require patience, says William Blair
01/16/20 Barrington
Blucora selloff on CEO departure a buying opportunity, says Barrington
01/13/20 JPMorgan
Blucora downgraded to Neutral from Overweight on deal risks at JPMorgan
BCOR Blucora
$9.04 /

+0.06 (+0.67%)

Recommendations
Seattle Genetics price target raised to $165 from $145 at Stifel » 07:24
09/22/20
09/22
07:24
09/22/20
07:24
SGEN

Seattle Genetics

/

+

, MRK

Merck

$83.11 /

-2.71 (-3.16%)

Stifel analyst Stephen…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SGEN Seattle Genetics
/

+

MRK Merck
$83.11 /

-2.71 (-3.16%)

SGEN Seattle Genetics
/

+

06:11 Today JMP Securities
Seattle Genetics price target raised to $200 from $185 at JMP Securities
09/21/20 Piper Sandler
Tisotumab data sets Seattle Genetics up for another approval, says Piper Sandler
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/15/20 SVB Leerink
Seattle Genetics price target raised to $185 from $173 at SVB Leerink
MRK Merck
$83.11 /

-2.71 (-3.16%)

09/21/20 Piper Sandler
Regeneron's Libtayo delivered results on par with Keytruda, says Piper Sandler
09/15/20 SVB Leerink
Seattle Genetics price target raised to $185 from $173 at SVB Leerink
09/14/20 RBC Capital
Seattle Genetics price target raised to $191 from $175 at RBC Capital
09/14/20 Piper Sandler
Seattle Genetics price target raised to $172 from $165 at Piper Sandler
SGEN Seattle Genetics
/

+

MRK Merck
$83.11 /

-2.71 (-3.16%)

MRK Merck
$83.11 /

-2.71 (-3.16%)

SGEN Seattle Genetics
/

+

MRK Merck
$83.11 /

-2.71 (-3.16%)

MRK Merck
$83.11 /

-2.71 (-3.16%)

Recommendations
Aurora Cannabis price target lowered to C$10 from C$21 at Canaccord » 07:24
09/22/20
09/22
07:24
09/22/20
07:24
ACB

Aurora Cannabis

$6.33 /

-0.2 (-3.06%)

Canaccord analyst Matt…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACB Aurora Cannabis
$6.33 /

-0.2 (-3.06%)

ACB Aurora Cannabis
$6.33 /

-0.2 (-3.06%)

09/21/20 Jefferies
Jefferies upgrades Aurora Cannabis to Hold, cuts price target to C$8.70
09/21/20 Jefferies
Aurora Cannabis upgraded to Hold from Underperform at Jefferies
09/09/20 Stifel
Aurora Cannabis price target lowered to C$10.50 from C$16 at Stifel
09/09/20 Cantor Fitzgerald
Aurora Cannabis price target lowered to C$17.50 from C$29 at Cantor Fitzgerald
ACB Aurora Cannabis
$6.33 /

-0.2 (-3.06%)

ACB Aurora Cannabis
$6.33 /

-0.2 (-3.06%)

ACB Aurora Cannabis
$6.33 /

-0.2 (-3.06%)

ACB Aurora Cannabis
$6.33 /

-0.2 (-3.06%)

Recommendations
Accenture price target raised to $255 from $240 at Wedbush » 07:21
09/22/20
09/22
07:21
09/22/20
07:21
ACN

Accenture

$233.94 /

-2.17 (-0.92%)

Wedbush analyst Moshe…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACN Accenture
$233.94 /

-2.17 (-0.92%)

ACN Accenture
$233.94 /

-2.17 (-0.92%)

06:08 Today Piper Sandler
Accenture price target raised to $229 from $206 at Piper Sandler
09/21/20 BMO Capital
Accenture price target raised to $255 from $215 at BMO Capital
09/21/20 Barclays
Accenture price target raised to $260 from $240 at Barclays
09/20/20 Citi
Accenture price target raised to $269 from $247 at Citi
ACN Accenture
$233.94 /

-2.17 (-0.92%)

ACN Accenture
$233.94 /

-2.17 (-0.92%)

ACN Accenture
$233.94 /

-2.17 (-0.92%)

ACN Accenture
$233.94 /

-2.17 (-0.92%)

Hot Stocks
Lexaria Bioscience granted DehydraTECH technology patent from USPTO » 07:21
09/22/20
09/22
07:21
09/22/20
07:21
LXRP

Lexaria Bioscience

$0.00 /

+ (+0.00%)

Lexaria Bioscience…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LXRP Lexaria Bioscience
$0.00 /

+ (+0.00%)

Recommendations
Cubic strategy validated by Elliott stake, says Canaccord » 07:21
09/22/20
09/22
07:21
09/22/20
07:21
CUB

Cubic

$59.56 /

+15.18 (+34.20%)

Canaccord analyst Ken…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CUB Cubic
$59.56 /

+15.18 (+34.20%)

CUB Cubic
$59.56 /

+15.18 (+34.20%)

06:46 Today RBC Capital
Cubic price target raised to $52 from $48 at RBC Capital
09/21/20 Citi
Elliott's interest in Cubic supportive of underlying value, says Citi
09/16/20 Citi
Cubic price target raised to $60 from $50 at Citi
09/15/20 JPMorgan
Cubic price target raised to $61 from $56 at JPMorgan
CUB Cubic
$59.56 /

+15.18 (+34.20%)

CUB Cubic
$59.56 /

+15.18 (+34.20%)

CUB Cubic
$59.56 /

+15.18 (+34.20%)

Recommendations
Morgan Stanley says Cree poised to benefit from investments in EV, clean energy » 07:20
09/22/20
09/22
07:20
09/22/20
07:20
CREE

Cree

$58.35 /

-3.97 (-6.37%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CREE Cree
$58.35 /

-3.97 (-6.37%)

09/04/20 Canaccord
Cree design wins add $1B market opportunity, says Canaccord
08/20/20 Citi
Cree price target lowered to $71 from $82 at Citi
08/19/20 Roth Capital
Cree downgraded to Neutral from Buy at Roth Capital
08/19/20 Wells Fargo
Cree price target raised to $65 from $45 at Wells Fargo
CREE Cree
$58.35 /

-3.97 (-6.37%)

CREE Cree
$58.35 /

-3.97 (-6.37%)

CREE Cree
$58.35 /

-3.97 (-6.37%)

CREE Cree
$58.35 /

-3.97 (-6.37%)

Recommendations
Illumina price target lowered to $300 from $350 at Canaccord » 07:16
09/22/20
09/22
07:16
09/22/20
07:16
ILMN

Illumina

$269.60 /

-25.695 (-8.70%)

Canaccord analyst Max…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ILMN Illumina
$269.60 /

-25.695 (-8.70%)

ILMN Illumina
$269.60 /

-25.695 (-8.70%)

07:07 Today Baird
Illumina price target lowered to $281 from $335 at Baird
06:17 Today Citi
Illumina acquisition 'adds ambiguity' around valuation, says Citi
06:08 Today UBS
Illumina downgraded to Neutral from Buy at UBS
06:00 Today Stifel
Stifel downgrades Illumina to Hold after 'massively dilutive' deal
ILMN Illumina
$269.60 /

-25.695 (-8.70%)

ILMN Illumina
$269.60 /

-25.695 (-8.70%)

ILMN Illumina
$269.60 /

-25.695 (-8.70%)

ILMN Illumina
$269.60 /

-25.695 (-8.70%)

Hot Stocks
AutoZone up 5.4% to $1,250 after Q4 results beat estimates  07:14
09/22/20
09/22
07:14
09/22/20
07:14
AZO

AutoZone

$1,181.71 /

-22.41 (-1.86%)

 
ShowHide Related Items >><<
AZO AutoZone
$1,181.71 /

-22.41 (-1.86%)

AZO AutoZone
$1,181.71 /

-22.41 (-1.86%)

09/18/20 DA Davidson
AutoZone expected to outperform Q4 consensus estimates, says DA Davidson
09/17/20 Morgan Stanley
AutoZone price target raised to $1,505 from $1,140 at Morgan Stanley
09/14/20 Wells Fargo
AutoZone price target raised to $1,375 from $1,300 at Wells Fargo
09/08/20 Atlantic Equities
AutoZone upgraded to Overweight from Neutral at Atlantic Equities
AZO AutoZone
$1,181.71 /

-22.41 (-1.86%)

Hot Stocks
AIM ImmunoTech announces pancreatic cancer survival results from EAP » 07:14
09/22/20
09/22
07:14
09/22/20
07:14
AIM

AIM ImmunoTech

$2.05 /

-0.03 (-1.44%)

AIM ImmunoTech announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AIM AIM ImmunoTech
$2.05 /

-0.03 (-1.44%)

AIM AIM ImmunoTech
$2.05 /

-0.03 (-1.44%)

04/06/20 Maxim
AIM ImmunoTech price target raised to $5 from $2 at Maxim
10/10/19 Maxim
AIM ImmunoTech has removed financing overhang, says Maxim
10/10/19 Maxim
AIM ImmunoTech upgraded to Buy from Hold at Maxim
AIM AIM ImmunoTech
$2.05 /

-0.03 (-1.44%)

AIM AIM ImmunoTech
$2.05 /

-0.03 (-1.44%)

Recommendations
Sykes Enterprises desiganted as a Fresh Pick at Baird » 07:13
09/22/20
09/22
07:13
09/22/20
07:13
SYKE

Sykes Enterprises

$31.55 /

-1.5 (-4.54%)

Baird analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SYKE Sykes Enterprises
$31.55 /

-1.5 (-4.54%)

06/04/20 Baird
Sykes Enterprises upgraded to Outperform at Baird
06/04/20 Baird
Sykes Enterprises upgraded to Outperform from Neutral at Baird
03/16/20 Sidoti
Sykes Enterprises upgraded to Buy from Neutral at Sidoti
11/11/19 Sidoti
Sykes Enterprises downgraded to Neutral on valuation at Sidoti
SYKE Sykes Enterprises
$31.55 /

-1.5 (-4.54%)

SYKE Sykes Enterprises
$31.55 /

-1.5 (-4.54%)

Hot Stocks
LiveXLive Media announces expansion in Latin America » 07:13
09/22/20
09/22
07:13
09/22/20
07:13
LIVX

LiveXLive Media

$2.78 /

-0.23 (-7.64%)

LiveXLive Media announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LIVX LiveXLive Media
$2.78 /

-0.23 (-7.64%)

LIVX LiveXLive Media
$2.78 /

-0.23 (-7.64%)

08/07/20 H.C. Wainwright
LiveXLive Media price target raised to $6 from $4.50 at H.C. Wainwright
06/19/20 Alliance Global Partners
LiveXLive Media price target raised to $6 from $5.50 at Alliance Global Partners
06/19/20 Ladenburg
LiveXLive Media price target raised to $5.75 from $4.50 at Ladenburg
05/11/20 Alliance Global Partners
LiveXLive Media price target raised to $5.50 from $4 at Alliance Global Partners
LIVX LiveXLive Media
$2.78 /

-0.23 (-7.64%)

LIVX LiveXLive Media
$2.78 /

-0.23 (-7.64%)

LIVX LiveXLive Media
$2.78 /

-0.23 (-7.64%)

Recommendations
PPD, Inc. price target raised to $38 from $35 at Mizuho » 07:13
09/22/20
09/22
07:13
09/22/20
07:13
PPD

PPD, Inc.

$34.14 /

+0.29 (+0.86%)

Mizuho analyst Ann Hynes…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PPD PPD, Inc.
$34.14 /

+0.29 (+0.86%)

PPD PPD, Inc.
$34.14 /

+0.29 (+0.86%)

09/21/20 Baird
PPD, Inc. price target raised to $40 from $36 at Baird
08/06/20 Mizuho
PPD, Inc. price target raised to $35 from $29 at Mizuho
08/06/20 Citi
PPD, Inc. price target raised to $37 from $31 at Citi
08/05/20 Credit Suisse
PPD, Inc. price target raised to $35 from $30 at Credit Suisse
PPD PPD, Inc.
$34.14 /

+0.29 (+0.86%)

  • 17
    Sep
  • 06
    Feb
PPD PPD, Inc.
$34.14 /

+0.29 (+0.86%)

Recommendations
Wave Life recent volatility not due to fundamentals, says Mizuho » 07:11
09/22/20
09/22
07:11
09/22/20
07:11
WVE

Wave Life Sciences

$15.02 /

-4.6 (-23.45%)

Mizuho analyst Salim Syed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WVE Wave Life Sciences
$15.02 /

-4.6 (-23.45%)

WVE Wave Life Sciences
$15.02 /

-4.6 (-23.45%)

02/07/20 Guggenheim
Guggenheim starts NeuBase Therapeutics at Buy with $13 price target
01/02/20 H.C. Wainwright
H.C. Wainwright cuts Wave Life price target to $20, but 'not throwing in towel'
12/31/19
Fly Intel: Top five analyst actions
12/31/19 Guggenheim
Wave Huntington's data 'mediocre, but not a zero,' says Guggenheim
WVE Wave Life Sciences
$15.02 /

-4.6 (-23.45%)

WVE Wave Life Sciences
$15.02 /

-4.6 (-23.45%)

WVE Wave Life Sciences
$15.02 /

-4.6 (-23.45%)

Hot Stocks
UCB: FDA, EMA accept BLA, MAA for bimekizumab » 07:11
09/22/20
09/22
07:11
09/22/20
07:11
UCBJY

UCB

$0.00 /

+ (+0.00%)

UCB announced that the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UCBJY UCB
$0.00 /

+ (+0.00%)

07/31/20 UBS
UCB downgraded to Neutral from Buy at UBS
07/28/20 JPMorgan
UCB price target raised to EUR 124 from EUR 114 at JPMorgan
06/15/20 Oddo BHF
UCB upgraded to Buy from Neutral at Oddo BHF
05/18/20 Jefferies
Jefferies names Beazley, Ferguson, Novartis, Rio Tinto high conviction ideas
Earnings
CoreLogic raises FY21 revenue view to $1.97B-$2.01B from $1.91B-$1.95B » 07:10
09/22/20
09/22
07:10
09/22/20
07:10
CLGX

CoreLogic

$67.54 /

+0.23 (+0.34%)

Consensus $1.88B. Raises…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLGX CoreLogic
$67.54 /

+0.23 (+0.34%)

CLGX CoreLogic
$67.54 /

+0.23 (+0.34%)

07/24/20
Fly Intel: Top five analyst downgrades
07/24/20 Stephens
Stephens sees limited further upside for CoreLogic shares, cuts to Equal Weight
07/24/20 Stephens
CoreLogic downgraded to Equal Weight from Overweight at Stephens
07/24/20 Compass Point
CoreLogic downgraded to Neutral from Buy at Compass Point
CLGX CoreLogic
$67.54 /

+0.23 (+0.34%)

CLGX CoreLogic
$67.54 /

+0.23 (+0.34%)

CLGX CoreLogic
$67.54 /

+0.23 (+0.34%)

Initiation
Aldeyra initiated with a Buy at Alliance Global Partners » 07:10
09/22/20
09/22
07:10
09/22/20
07:10
ALDX

Aldeyra

$6.97 /

-0.44 (-5.94%)

Alliance Global Partners…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALDX Aldeyra
$6.97 /

-0.44 (-5.94%)

ALDX Aldeyra
$6.97 /

-0.44 (-5.94%)

06/04/20 JonesTrading
Aldeyra pact with FDA may point to 'surer path' for approval, says JonesTrading
05/11/20 Oppenheimer
Aldeyra initiated with an Outperform at Oppenheimer
12/03/19 JonesTrading
Aldeyra dry eye data positive nearly across the board, says JonesTrading
10/22/19 Cantor Fitzgerald
Aldeyra assumed with an Overweight at Cantor Fitzgerald
ALDX Aldeyra
$6.97 /

-0.44 (-5.94%)

ALDX Aldeyra
$6.97 /

-0.44 (-5.94%)

Recommendations
Ionis Pharmaceuticals price target raised to $59 from $56 at Cantor Fitzgerald » 07:10
09/22/20
09/22
07:10
09/22/20
07:10
IONS

Ionis Pharmaceuticals

$50.24 /

-1.15 (-2.24%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IONS Ionis Pharmaceuticals
$50.24 /

-1.15 (-2.24%)

IONS Ionis Pharmaceuticals
$50.24 /

-1.15 (-2.24%)

09/14/20 JPMorgan
Ionis Pharmaceuticals resumed with a Neutral at JPMorgan
09/08/20 Citi
Ionis Pharmaceuticals price target lowered to $74 from $78 at Citi
09/02/20 Benchmark
Benchmark starts Ionis at Hold, cautious on Spinraza competition
09/02/20 Benchmark
Ionis Pharmaceuticals initiated with a Hold at Benchmark
IONS Ionis Pharmaceuticals
$50.24 /

-1.15 (-2.24%)

IONS Ionis Pharmaceuticals
$50.24 /

-1.15 (-2.24%)

Hot Stocks
Neptune Wellness announces partnership » 07:10
09/22/20
09/22
07:10
09/22/20
07:10
NEPT

Neptune Wellness

$2.40 /

-0.1 (-4.00%)

Neptune Wellness…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NEPT Neptune Wellness
$2.40 /

-0.1 (-4.00%)

NEPT Neptune Wellness
$2.40 /

-0.1 (-4.00%)

08/27/20 Alliance Global Partners
Neptune Wellness deal shows ability to succeed in traditonal category, says AGP
08/07/20
Fly Intel: Top analyst initiations
08/07/20 Alliance Global Partners
Neptune Wellness initiated with a Buy at Alliance Global Partners
01/31/20 Cowen
Neptune Wellness initiated with a Market Perform at Cowen
NEPT Neptune Wellness
$2.40 /

-0.1 (-4.00%)

NEPT Neptune Wellness
$2.40 /

-0.1 (-4.00%)

Hot Stocks
Medipharm Labs to supply cannabis oil to XLR8 Brazil » 07:09
09/22/20
09/22
07:09
09/22/20
07:09
MEDIF

Medipharm Labs

$0.00 /

+ (+0.00%)

MediPharm Labs announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MEDIF Medipharm Labs
$0.00 /

+ (+0.00%)

MEDIF Medipharm Labs
$0.00 /

+ (+0.00%)

MEDIF Medipharm Labs
$0.00 /

+ (+0.00%)

Recommendations
Nike price target raised to $115 but limited upside seen, says Baird » 07:09
09/22/20
09/22
07:09
09/22/20
07:09
NKE

Nike

$113.31 /

-1.32 (-1.15%)

Baird analyst Jonathan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NKE Nike
$113.31 /

-1.32 (-1.15%)

NKE Nike
$113.31 /

-1.32 (-1.15%)

09/18/20 Needham
Nike price target raised to $132 from $113 at Needham
09/18/20 Morgan Stanley
Nike price target raised to $142 from $121 at Morgan Stanley
09/18/20 Raymond James
Nike price target raised to $121 from $115 at Raymond James
09/18/20 Barclays
Nike price target raised to $132 from $118 at Barclays
NKE Nike
$113.31 /

-1.32 (-1.15%)

NKE Nike
$113.31 /

-1.32 (-1.15%)

NKE Nike
$113.31 /

-1.32 (-1.15%)

NKE Nike
$113.31 /

-1.32 (-1.15%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.